GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we approach high blood sugar. These injectable therapies work by imitating the body’s own GLP-1 https://imogeneceo533049.aboutyoublog.com/54370721/glp-1-a-significant-breakthrough-in-glucose-treatment